Clinical trial

A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0…

NCT00238875 · Haruhiko Fukuda, Other · Completed

Key facts

NCT number NCT00238875
Title A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403)
Official title A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403)
Lead sponsor Haruhiko Fukuda, Other
Collaborators Ministry of Health, Labour and Welfare, Japan
Status Completed
Phase Phase 2
Study type Interventional
Conditions T1N0M0 Non-small Cell Lung Cancer
Intervention type Procedure
Interventions stereotactic body radiation therapy
Enrollment 167
Start date Jul 1, 2004
Primary completion Nov 1, 2011
Completion Nov 1, 2011
First posted Oct 14, 2005
Last update posted Sep 22, 2016
Countries Japan

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies